Non-invasive diagnosis and follow-up of primary biliary cholangitis - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Clinics and Research in Hepatology and Gastroenterology Année : 2022

Non-invasive diagnosis and follow-up of primary biliary cholangitis

Résumé

Non-invasive diagnosis and follow-up of primary biliary cholangitis Summary Primary biliary cholangitis (PBC) is a chronic inflammatory disease of the intrahepatic bile ducts [1]. It is characterised biologically by chronic cholestasis associated with the presence of specific autoantibodies, and histologically by lesions of nonsuppurative destructive cholangitis. If left untreated it can progress to cirrhosis, portal hypertension and liver failure. Diagnosis, staging and follow-up are largely based on non-or minimally-invasive assessment (blood tests, ultrasound, liver stiffness measurement). Histological examination of the liver and upper gastrointestinal endoscopy are sometimes necessary, but their indications remain limited. The purpose of this chapter is to provide the clinicians with what should be known about the non-invasive assessment of PBC and to provide specific recommendations for clinical practice.

Mots clés

PBC
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-03664674 , version 1 (11-05-2022)

Identifiants

Citer

Christophe Corpechot, Alexandra Heurgue, Florence Tanne, Pascal Potier, Bertrand Hanslik, et al.. Non-invasive diagnosis and follow-up of primary biliary cholangitis. Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (1), pp.101770. ⟨10.1016/j.clinre.2021.101770⟩. ⟨inserm-03664674⟩
24 Consultations
7 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More